Three Old Economy Dow Stocks Deliver Big Beats
In a year marked by AI-driven cost cuts and capital-light efficiency, three Dow components long tagged as old economy stocks have outpaced both the S&P 500 and the Dow itself. Investors are rediscovering these names for their hard-asset moats, global reach, and ability to translate cycles into steady cash flow.
Public markets tend to reward firms with predictable pricing power, scalable platforms, and real-world assets that can weather inflation and rate swings. These traits are also what help the trio maintain relevance even as technology and services reshape many corners of the economy. Here is a closer look at the three members quietly leading the pack.
Stocks in Focus
- CVS Health Corp (CVS) — Shares have jumped roughly 52% over the last 12 months. The Q1 2026 report showed adjusted EPS of about 2.57, beating the consensus by more than 16%, on revenue near 100.4B. Aetna’s health care benefits segment posted a sharp rise in adjusted operating income, while the medical benefit ratio edged lower, signaling improving profitability on selling and administering care.
- Goldman Sachs Group Inc (GS) — The stock has surged about 71% in the year through this spring. The firm posted a solid Q4 2025 with earnings per share around 14.01, well above the street estimate, reflecting strength across trading, investment banking, and asset management. AI-driven workflows and risk-management technology have become a larger portion of revenue and efficiency gains.
- Deere & Company (DE) — Deere has gained roughly 38% over the past year. The company’s equipment and precision farming solutions benefited from resilient farm income and improving margins as supply chains normalized. Industry demand for machinery and data-enabled product lines supported a robust earnings rhythm into late 2025 and beyond.
What Ties These Stocks Together
- Hard-asset moats backed by global networks and durable franchises that can scale without losing pricing power.
- B2B exposure and cycle sensitivity that align with infrastructure spending, farming activity, and wealth markets.
- Dominant market positions that create steep scale barriers and long-run cash-flow visibility.
AI and the Earnings Beat
Across these names, AI and automation are not merely buzzwords; they are practical tools that streamline operations, optimize pricing, and shorten decision cycles. In CVS Health, real-time authorizations and health-tech initiatives around AI-powered claims processing are trimming costs and speeding care pathways. Goldman Sachs is piloting AI-enhanced workflow solutions across trading and advisory services, sharpening execution and client outcomes. Deere deploys data analytics and autonomous guidance within manufacturing and precision agriculture to boost productivity and field performance.
Analysts say these advantages translate into steadier earnings streams that power dividend resilience and buyback activity, even as macro headlines shift. “AI-driven efficiency is lifting profits across asset-heavy businesses,” noted a senior analyst who watches the industrials and services spaces. “The result is not a one-off gain; it’s a combination of cost control plus revenue resilience that these ‘old economy’ stocks are leveraging.”
Market Context and Timing
As of mid-2026, the market is digesting a mix of slower consumer inflation, steadier rates, and a continued push toward automation across industries. Investors are increasingly drawn to franchises with long-run cash-flow visibility and the ability to convert cyclical upswings into durable earnings. In this environment, these ‘old economy’ stocks are drawing attention for their reliability and the strategic role AI can play in enhancing traditional business models.
Another factor is valuation. Analysts have perched price-earnings ranges that still reflect a modest premium given their risk profiles and cash-flow certainty. For CVS, the forward multiple sits in a mid-teens territory in some scenarios, reflecting the ongoing regulatory and reimbursement dynamics yet balanced by a strong retail in-network model. Goldman Sachs trades at undemanding levels relative to growth and returns from capital markets activity, while Deere’s multiple reflects steady agricultural demand and an improving mix of equipment solutions versus price pressure in raw materials.
Risks on the Horizon
Despite the strong run, these stocks face challenges common to the old economy: regulatory shifts in healthcare and drug pricing; volatility in capital markets tied to monetary policy expectations; and agricultural commodity cycles that can swing farm equipment demand. In CVS’s case, payer reimbursement pressure and possible goodwill implications continue to loom. For Goldman Sachs, a slower deal pipeline or a shift in market sentiment could test earnings durability. Deere must weather crop yields, weather variability, and evolving farm policy across major markets.
Investor Takeaway
These ‘old economy’ stocks are not relics of a bygone era; they are proving that real assets, scale, and cash-flow discipline can still outperform in a tech-saturated era. The AI wave is not the sole driver, but it amplifies the advantages of these franchises by slashing costs and speeding service delivery, a combination investors crave in today’s uncertain market. For traders and long-term holders alike, the story remains clear: these ‘old economy’ stocks offer a blend of resilience, innovation, and market discipline that can help weather volatility while still chasing above-average returns.
Bottom Line
These ‘old economy’ stocks have turned into leaders in a market defined by rapid change. CVS Health, Goldman Sachs, and Deere each show how hard assets, scale, and AI-enabled processes can translate into meaningful earnings beats and outperformance. As the investment landscape evolves, these firms serve as reminders that classic moats can coexist with modern tech, delivering results that traders should watch closely.
Discussion